PetLife Pharmaceuticals, Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/34c71412-b598-4e22-bf1a-96c854295b88/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2017 | $-22.7M | 2016-09-01 – 2017-08-31 | evidence 0001493152-17-014624 |
| FY 2016 | $-3.7M | 2015-09-01 – 2016-08-31 | evidence 0001493152-16-016114 |
| FY 2015 | $-1.9M | 2014-09-01 – 2015-08-31 | evidence 0001493152-16-006631 |
| FY 2014 | $-1.5M | 2013-09-01 – 2014-08-31 | evidence 0001493152-15-006481 |
| FY 2013 | $-5.1M | 2010-11-09 – 2014-05-31 | evidence 0001079974-14-000573 |
| FY 2012 | $-2.6M | 2011-09-01 – 2012-08-31 | evidence 0001079974-14-000556 |
| FY 2011 | $-2.0M | 2010-11-09 – 2012-05-31 | evidence 0001096906-12-001843 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).